Paulo Francisco Veiga Bizerra is a researcher in Biological Sciences with expertise in biochemistry, metabolism, and molecular biology. He earned his degree in Animal Science and his Master’s in Animal Science and Technology from São Paulo State University (UNESP), followed by a PhD in Biological Sciences from the State University of Maringá (UEM). During his doctoral studies, he uncovered how impairments in mitochondrial bioenergetics contribute to the acute hepatotoxic effects of the antidepressant clomipramine.
As part of a sandwich PhD program at the Tytgat Institute, University of Amsterdam, Paulo investigated liver immune cells and the signaling pathways of Soluble Adenylyl Cyclase (sAC). His work demonstrated that canonical transmembrane adenylyl cyclase–cAMP–PKA signaling promotes glycogenolysis, while non‑canonical sAC–cAMP–Epac1 signaling suppresses it.
After completing his PhD, Paulo served as a temporary lecturer in Biochemistry at UNESP and pursued postdoctoral research in neurobiology at the University of Campinas (UNICAMP). He is currently a postdoctoral researcher in Maschalidi lab at Ghent University, where he studies the phagocytic clearance of apoptotic cells for better wound healing during primary skin injury repair and upon secondary assaults.
